New Jersey-based pharmaceutical company Pacira Biosciences, Inc. (PCRX) has signed an agreement to acquire biopharmaceutical firm Flexion Therapeutics, Inc.
The Federal Reserve, for now, remains committed to its low-rate policy, so the stock market is the place to look for investors seeking …
As we round the corner on the current decade, investors are laser focused on the market, trying to determine what’s in the cards …
Along with healthcare stocks in general, biotechnology stocks are not hitting any near-term highs in terms of share price performance. Chalk it up …
Flexion Therapeutics Inc (NASDAQ:FLXN) investors have a smile on their faces Friday evening, after the drug maker announced that the FDA approved its osteoarthritis knee …
Insider transactions can be the foundation of numerous trading strategies and signals. For example, we found that a strategy based on only top-ranked …
Flexion Therapeutics Inc (NASDAQ:FLXN) investors have sent shares racing 38% on back of media buzz painting the arc of a prospective takeout, courtesy …
Flexion Therapeutics Inc (NASDAQ:FLXN) shares are on the rise today on the back of rumors that Sanofi (NYSE:SNY) is in talks to acquire …
Abercrombie & Fitch Co. (NYSE:ANF) is down close to 12% in pre-market trading after the firm released disappointing 1Q:16 earnings this morning.
